Frontiers in the pathogenesis of Alzheimer’s disease
2009

Understanding Alzheimer's Disease Pathogenesis

publication Evidence: moderate

Author Information

Author(s): Sambamurti Kumar, Jagannatha Rao K. S., Pappolla Miguel A.

Primary Institution: Medical University of South Carolina

Hypothesis

The aggregation of amyloid β protein (Aβ) induces neurodegeneration in Alzheimer's disease.

Conclusion

Alzheimer's disease is a complex condition that requires a broad-based approach to identify mechanisms of neurodegeneration and develop effective treatments.

Supporting Evidence

  • Alzheimer's disease affects 12 million people worldwide, with the number expected to triple by 2050.
  • The disease is characterized by the presence of amyloid plaques and neurofibrillary tangles in the brain.
  • Current treatments only provide short-term symptom relief and do not prevent neurodegeneration.

Takeaway

Alzheimer's disease is when people slowly lose their memory and ability to think, and scientists are trying to find better ways to treat it.

Limitations

Current treatments only address symptoms and do not stop the disease's progression.

Participant Demographics

Alzheimer's disease primarily affects elderly individuals, with a prevalence rate of about 7% for those aged 65 and older.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication